NASDAQ:RPTX
Delisted

Repare Therapeutics Stock Predictions

etoro logo Buy RPTX
*Your capital is at risk
$2.65
+0 (+0%)
At Close: Apr 24, 2026
Currently predicting for Mon, 8 Jun 2026

RPTX Prediction Chart

RPTX Predictions History

Latest community submissions for RPTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 4, 2025 Bullish $1.69 X 0
Jul 16, 2025 $1.45 +1.28% $1.53 V 94.66% 1
Jul 16, 2025 $5.24 +233.76% Unrealistic Excluded from avg $1.53 X 0.00% 1
Jul 15, 2025 $1.54 -1.61% $1.43 V 91.98% 1
Jul 15, 2025 $1.55 -1.01% $1.43 V 91.32% 1
Jul 15, 2025 $6.50 +333.33% Unrealistic Excluded from avg $1.43 X 0.00% 0
Dec 5, 2023 $5.16 -2.49% $5.34 X 96.59% 0
Dec 5, 2023 $5.08 -3.99% $5.34 X 95.11% 0
Dec 5, 2023 Bullish $5.34 V 1
JS JS Pro
Dec 4, 2023 $5.37 +0.94% $5.29 X 98.49% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RPTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT REPARE THERAPEUTICS INC.
Repare Therapeutics
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an ora...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE